Ellery Mangas

Ellery Mangas serves as Vice President, Regulatory Affairs at Neurogene Inc. Mr. Mangas is a regulatory professional with more than 25 years of experience managing global regulatory activities for both small and large molecule development programs and has led products through all critical stages of development; from research to first-in-human studies, from early to late phase clinical evaluation and from license application through approval and post-marketing development. In his role at Neurogene, he provides strategic and operational guidance for both domestic and international regulatory engagement. His areas of therapeutic focus have included rare and common neurological, immunological, cardiovascular and infectious diseases with a wide array of drug delivery approaches. Prior to joining Neurogene, Mr. Mangas held regulatory positions of increasing responsibility at AGTC, UCB, Nabi Biopharmaceuticals and COR Therapeutics. Ellery earned a B.S. degree in Microbiology and Cell Science from the University of Florida and is Regulatory Affairs Certified by the Regulatory Affairs Professionals Society (RAPS).